Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)

Cabio Biotech (Wuhan) Revenue

In the year 2025, Cabio Biotech (Wuhan) had annual revenue of 574.88M CNY with 3.47% growth. Cabio Biotech (Wuhan) had revenue of 146.86M in the quarter ending December 31, 2025, a decrease of -12.82%.

• Revenue: 574.88M
• Revenue Growth: +3.47%
• P/S Ratio: 5.65
• Revenue / Employee: 1.02M
• Employees: 574
• Market Cap: 3.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	574.88M	19.29M	3.47%
Dec 31, 2024	555.59M	111.79M	25.19%
Dec 31, 2023	443.80M	10.38M	2.39%
Dec 31, 2022	433.42M	82.32M	23.44%
Dec 31, 2021	351.11M	27.65M	8.55%